# Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

> **NCT05788991** · PHASE4 · TERMINATED · sponsor: **Medinova AG** · enrollment: 151 (actual)

## Conditions studied

- Bacterial Vaginosis
- Vaginal Infection
- Vaginal Diseases

## Interventions

- **DRUG:** Dequalinium Chloride
- **DRUG:** Metronidazole Oral

## Key facts

- **NCT ID:** NCT05788991
- **Lead sponsor:** Medinova AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-26
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-08-25
- **Target enrollment:** 151 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05788991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05788991, "Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05788991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*